Is the price fair?
What BHC's price assumes
Bausch Health Companies Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 0.19× revenue.
0.19
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 2.04
EV / sales
Details›
- EV / EBIT2026-Q1
- 36.6
- EV / sales2026-Q1
- 2.04
- Market capitalisation
- $1.78B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers - Specialty & Generic
Ranks #20 of 28 by Smart Score